Smoking and Clozapine: Can You Take Them Together?

High — Consult Your Doctorconflict
Evidence-gradedLast reviewed June 1, 2026Source: Lucas C, Martin J. Smoking and drug interactions. Aust Prescr. 2013
Learn about each ingredient:SmokingClozapine

Quick answer

Polycyclic aromatic hydrocarbons in tobacco smoke (not nicotine) strongly induce CYP1A2, the liver enzyme that handles most clozapine metabolism, so smokers tend to have lower clozapine levels and need higher doses. The greater danger is stopping smoking: levels can climb sharply over a few days as the enzyme returns to baseline, risking sedation, seizures, and toxicity unless the dose is reviewed.

Tell your prescriber if you smoke, and notify them before any planned change in smoking status, including hospital admissions to smoke-free units, residential or surgical stays, or quit attempts. Because stopping smoking can raise clozapine levels within days, a dose reduction and plasma level monitoring are usually needed. Nicotine replacement does not cause this interaction. Do not change clozapine on your own; review with your doctor or pharmacist.

What happens?

Tobacco smoke speeds up the liver enzyme that breaks down clozapine, so starting or stopping smoking can shift your clozapine blood levels within a few days. That makes any change in smoking status something to manage deliberately rather than ignore.

1

Smoke induces CYP1A2

Cigarette smoke contains polycyclic aromatic hydrocarbons (PAHs) that are among the most potent inducers of the liver enzyme CYP1A2. It is the PAHs in the smoke, not the nicotine, that drive this effect.

2

Lower while smoking

Clozapine is broken down mainly by CYP1A2. While you smoke regularly, the induced enzyme clears clozapine faster, so levels tend to run lower and smokers often need a higher daily dose for the same effect.

3

Climbing on quitting

When smoking stops, CYP1A2 activity falls back toward baseline over a few days. Clozapine levels can rise substantially in that short window, beginning almost immediately even with no change to the prescribed dose.

The interaction is driven by the <strong>smoke</strong>, not the nicotine, so nicotine patches, gum, and lozenges do not induce CYP1A2 and do not require a clozapine dose change.

Why is this important?

Clozapine has a narrow therapeutic window and is reserved for treatment-resistant schizophrenia precisely because of its serious side-effect profile. Relatively small swings in plasma level can have outsized clinical consequences.

Toxicity risk

Higher than expected clozapine levels increase the risk of seizures, profound sedation, low blood pressure on standing, severe constipation, myocarditis, and confusion.

The danger is quitting

This is one of the few interactions where the risk lies in stopping the habit rather than starting a drug. Published case reports describe clozapine toxicity, including grand mal seizures, in patients who quit smoking abruptly without any dose adjustment.

Hidden triggers

A psychiatric admission to a smoke-free unit, a hospital stay for an unrelated reason, or a serious quit attempt acts as a sudden quit and can turn a well-controlled outpatient into an acutely unwell one within a single week.

Conversely, someone stable on a higher dose while smoking who resumes smoking after a hospital stay may relapse as clozapine levels fall again.

What should you do?

The practical fix is simple: separate the doses.

Flag every change in smoking status in advance so the dose can be reviewed, not reacted to.

Best practical schedule

Before any planned change
Tell your psychiatrist before you quit, cut down, or enter any smoke-free setting (hospital admission, residential treatment, surgery, jail or prison) or start a quit attempt.
Around the change
Let your team plan a dose reduction together with plasma level checks before and after, and set the new dose and monitoring schedule with you.
Every day during a transition
Watch for new sedation, dizziness on standing, increased drooling, or constipation, and report these promptly.
After any change
Attend the follow-up clozapine plasma level test to confirm the dose is back in range.

Important reminders

  • It is the smoke, not the nicotine, that interacts.
  • Switching from cigarettes to nicotine replacement still counts as quitting for clozapine dosing.
  • Heavy cannabis smoking produces the same combustion products and should also be disclosed.
  • Do not stop or adjust clozapine on your own; abrupt discontinuation carries its own risks.
  • Tell every clinician you take clozapine and that you smoke, ideally before any admission.

Nicotine replacement (patches, gum, lozenges, inhalers, sprays) and most non-combustible nicotine products do not induce CYP1A2 and do not require a clozapine dose change, but still tell your prescriber you are quitting.

Which specific products are affected?

Many common Clozapine products can affect this interaction.

Clozapine brands affected

ClozarilFazaClo (orally disintegrating tablet)Versacloz (oral suspension)Generic clozapine tabletsGeneric clozapine orally disintegrating tablets

Combustible products that drive the interaction

CigarettesCigarsPipe tobaccoHookah / shishaCannabis joints

Other sources

  • Other CYP1A2 substrates that shift in parallel when smoking status changes: olanzapine, theophylline, duloxetine, ropinirole, tizanidine, and caffeine
  • Not expected to interact (negligible PAHs): smokeless tobacco (snus, chew, dip), nicotine pouches, nicotine patches, gum, lozenges, inhalers, sprays, and most e-cigarettes

The interaction applies to all brand and generic clozapine. It is the combustion smoke, not the nicotine, that matters, so non-combustible nicotine products are not expected to interact.

The bottom line

Smoke lowers clozapine levels by inducing CYP1A2, and quitting raises them within days, so any change in smoking status can push a stable patient out of range. The greatest risk is an unannounced quit, often during a smoke-free hospital stay, which can cause sedation, seizures, and toxicity. Tell your prescriber before any change in smoking status, including admissions and quit attempts, so the dose can be reviewed and plasma levels monitored.

Do not adjust clozapine yourself; review every change with your doctor or pharmacist.

What happens when you take smoking with clozapine?

Tobacco smoke speeds up the liver enzyme that breaks down clozapine. Because of this, starting or stopping smoking can move your clozapine blood levels within a few days, which is why this combination needs to be managed deliberately.

  1. Smoke induces CYP1A2. Cigarette smoke contains polycyclic aromatic hydrocarbons (PAHs) that are among the most potent known inducers of the liver enzyme CYP1A2. It is the PAHs in smoke, not the nicotine, that drive this effect.
  2. Clozapine relies on CYP1A2. Clozapine is broken down mainly by CYP1A2, so anything that speeds up or slows down that enzyme changes how much clozapine stays in your blood.
  3. Smoking lowers clozapine levels. While someone smokes regularly, the induced enzyme clears clozapine faster, so plasma concentrations tend to run lower than in a non-smoker on the same dose. Smokers therefore often need a higher daily dose to get the same effect.
  4. Quitting raises clozapine levels. When smoking stops, CYP1A2 activity falls back toward baseline over a few days. Clozapine levels can rise substantially in that short window, and they begin climbing almost immediately, even with no change to the prescribed dose.

Why is this important?

Clozapine has a narrow therapeutic window and is reserved for treatment-resistant schizophrenia precisely because of its serious side-effect profile. Relatively small swings in plasma level can have outsized clinical consequences.

Higher than expected clozapine levels increase the risk of seizures, profound sedation, low blood pressure on standing, severe constipation, myocarditis, and confusion. Published case reports describe clozapine toxicity, including grand mal seizures, in patients who quit smoking abruptly without any dose adjustment.

This is one of the few drug interactions where the danger lies in stopping an interacting habit rather than starting a drug. A psychiatric admission to a smoke-free unit, a hospital stay for an unrelated reason, or a serious quit attempt can turn a well-controlled outpatient into an acutely unwell one over the course of a single week. Conversely, someone who has been stable on a higher dose while smoking and then resumes smoking after a hospital stay may relapse as clozapine levels fall again.

What should you do?

The single most important step is to keep your prescriber informed about your smoking and to flag changes in advance, so the dose can be reviewed rather than reacted to after symptoms appear.

  • Before any planned change: Tell your psychiatrist before you quit, cut down, or enter any smoke-free setting (hospital admission, residential treatment, surgery, jail or prison) or start a quit attempt with nicotine replacement, varenicline, or bupropion.
  • Around the change: Because stopping smoking raises clozapine levels, prescribers usually plan a dose reduction together with plasma level checks before and after the change. Let your team set the new dose and the monitoring schedule with you.
  • Every day during a transition: Watch for new sedation, dizziness on standing, increased drooling, or constipation, and report these promptly.
  • After any change: Attend the follow-up clozapine plasma level test your team arranges to confirm the dose is back in range. Do not stop or adjust clozapine on your own; abrupt discontinuation carries its own risks of cholinergic rebound and rapid psychotic relapse.

Nicotine replacement (patches, gum, lozenges, inhalers, sprays) and most non-combustible nicotine products do not induce CYP1A2 and do not require a clozapine dose change. Switching from cigarettes to nicotine replacement still counts as "quitting smoking" for clozapine dosing.

Which specific products are affected?

The interaction applies to all brand and generic versions of clozapine, including Clozaril, FazaClo, and Versacloz, along with the orally disintegrating tablet and oral suspension forms.

The combustible products that drive the interaction include cigarettes, cigars, pipes, hookah, and cannabis joints, because they all produce polycyclic aromatic hydrocarbons. Heavy cannabis smoking can have a similar effect and should also be disclosed.

By contrast, smokeless tobacco (snus, chew, dip), nicotine pouches, nicotine patches, gum, lozenges, inhalers and sprays, and most e-cigarettes do not contain meaningful amounts of polycyclic aromatic hydrocarbons and are not expected to interact. Other medicines broken down by CYP1A2 that can shift in parallel when smoking status changes include olanzapine, theophylline, duloxetine, ropinirole, and tizanidine, and the same is true for caffeine.

The science behind it

The mechanism and direction of this interaction are well documented in the clinical literature.

  • Bondolfi G, et al. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients. Ther Drug Monit. 2005 (PMID 16044115). Two genotyped patients showed clozapine levels rising and side effects emerging after they stopped smoking, linking the change directly to reduced CYP1A2 activity.
  • McCarthy RH. Seizures following smoking cessation in a clozapine responder. Pharmacopsychiatry. 1994 (PMID 7838893). A case report describing seizures after smoking cessation in a patient stable on clozapine, illustrating the toxicity risk of de-induction.
  • Lucas C, Martin J. Smoking and drug interactions. Aust Prescr. 2013. A clinical review explaining that PAHs in smoke (not nicotine) induce CYP1A2 and that clozapine and other CYP1A2 substrates need dose review when smoking status changes.

Frequently Asked Questions

Is it the nicotine that interacts with clozapine?

No. The interaction is driven by the polycyclic aromatic hydrocarbons in combustion smoke, not by nicotine. That is why nicotine patches, gum, and similar products do not cause it.

Can I use nicotine replacement to quit while on clozapine?

Yes. Nicotine replacement does not induce CYP1A2, so it is appropriate to use while quitting. The clozapine dose change is driven by stopping the smoke itself, not by the nicotine product, so still tell your prescriber you are quitting.

Why is quitting smoking treated as the riskier change?

While you smoke, your clozapine dose has usually been set against an induced enzyme. When you stop, the enzyme slows down and clozapine levels can climb within days, so an unchanged dose can become too much. Starting smoking lowers levels and tends to reduce effectiveness rather than cause acute toxicity.

Do e-cigarettes and vaping interact with clozapine?

Most e-cigarettes do not produce meaningful polycyclic aromatic hydrocarbons, so they are not expected to interact. Even so, tell your prescriber if you switch to or from vaping so your clozapine can be reviewed.

What about cannabis?

Smoked cannabis also produces combustion products and can affect CYP1A2 in a similar way, so heavy cannabis smoking should be disclosed to your prescriber alongside tobacco use.

What should I do if I am admitted to a smoke-free hospital?

Tell every clinician involved in your care that you take clozapine and that you smoke, ideally before admission. A smoke-free stay is effectively a sudden quit, so your team can plan a dose review and monitoring rather than discovering toxicity after it appears.

Key takeaways

  • Smoking lowers clozapine levels by inducing CYP1A2; quitting raises them within days.
  • The interaction is driven by smoke, not nicotine, so nicotine replacement is appropriate while quitting.
  • The greatest risk is an unannounced quit, often during a smoke-free hospital stay.
  • Tell your prescriber before any change in smoking status so the dose can be reviewed and levels monitored.
  • Do not adjust clozapine yourself; review every change with your doctor or pharmacist.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Caffeine + Ciprofloxacin

moderate

Ciprofloxacin inhibits the liver enzyme CYP1A2, which is the main pathway that clears caffeine. As a result, caffeine is broken down more slowly, its blood levels stay higher for longer, and its stimulant effects are amplified and prolonged while you are on the antibiotic.

St. John's Wort + SSRI

high

St. John's Wort is pharmacologically active, not a harmless herb, and it interacts with SSRIs in two overlapping and hard-to-predict ways. The result is a combination most clinicians prefer to avoid rather than manage.

Alcohol + Lithium

high

Lithium has a narrow therapeutic window and is cleared almost entirely by the kidneys. Alcohol promotes urination and dehydration, which can reduce renal lithium clearance and push serum lithium levels higher — toward the toxic range (tremor, confusion, unsteadiness, vomiting). Alcohol also independently destabilizes mood in bipolar disorder, and its early intoxication signs can mask the early warning signs of lithium toxicity.

Sertraline + St. John's Wort

critical

Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently raises central serotonin through constituents such as hyperforin and hypericin. Combining them can trigger serotonin syndrome, a potentially life-threatening reaction marked by altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also induces CYP3A4 and CYP2C19, which can lower sertraline levels and undermine treatment.

Alcohol + Warfarin

critical

Alcohol affects warfarin in two opposing directions: acute heavy drinking slows the liver's metabolism of warfarin, which can raise INR and bleeding risk, while sustained heavy drinking induces those same enzymes and can lower INR, increasing clot risk. Alcohol also impairs platelets and can damage the liver where clotting factors are made, and intoxication raises fall risk, all of which compound the bleeding hazard.

Smoking + Vitamin C

moderate

Smoking increases oxidative stress and accelerates the body's turnover of vitamin C, leaving smokers with consistently lower blood and tissue levels of ascorbic acid than non-smokers eating the same diet. Because of this, expert nutrition bodies recommend that people who smoke aim for a higher daily vitamin C intake than non-smokers.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free